Viral effects on antigen processing

Current Opinion in Immunology

Volumn 11, Issue 1, 1999, Pages 94-99

  Miller, Daniel M ^a   Sedmak, Daniel D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN; VIRUS PROTEIN;

ALLELE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; DATA ANALYSIS; HUMAN; IMMUNOMODULATION; IMMUNOSURVEILLANCE; NATURAL KILLER CELL; NONHUMAN; REVIEW; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0033067895     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)80017-X     Document Type: Article

References (49)

1. Hengel H, Koszinowski UH Interference with antigen processing by viruses. Curr Opin Immunol. 9:1997;470-476.
2. Heemels MT, Ploegh H Generation, translocation, and presentation of MHC class I-restricted peptides. Annu Rev Biochem. 64:1995;463-491.
3. Gilbert MJ, Riddell SR, Plachter B, Greenberg PD Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature. 383:1996;720-722.
4. Levitskaya J, Sharipo A, Leonchiks A, Ciechanover A, Masucci MG Inhibition of ubiquitin/proteasome-dependent protein degradation by the gly-ala repeat domain of the epstein-barr virus nuclear antigen 1. Proc Natl Acad Sci USA. 94:1997;12616-12621.
5. Hengel H, Koopmann JO, Flohr T, Muranyi W, Goulmy E, Hammerling GJ, Koszinowski UH, Momburg F A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity. 6:1997;623-632.
6. Kwangseog A, Gruhler A, Galocha B, Jones TR, Wiertz EJHJ, Ploegh HL, Peterson PA, Yang Y, Fruh K The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity. 6:1997;613-621.
7. Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh HL, Johnson D Herpes simplex virus turns off the TAP to evade host immunity. Nature. 375:1995;411-415.
8. Tomazin R, Hill AB, Jugovich P, York I, van Endert P, Ploegh HL, Andrews DW, Johnson DC Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J. 15:1996;3256-3266.
9. Galocha B, Hill A, Barnett BC, Dolan A, Raimondi A, Cook RF, Brunner J, McGeoch DJ, Ploegh HL The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. J Exp Med. 185:1997;1565-1572. This paper describes the precise region of ICP47 that inhibits TAP activity; moreover, a second region of homology between HSV-1 and HSV-2 ICP47 suggests that there is another functional domain that remains to be characterized.
10. ••].
11. Jugovic P, Hill AM, Tomazin R, Ploegh H, Johnson DC Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and type 2 ICP47. J Virol. 72:1998;5076-5084.
12. Goldsmith K, Chen W, Johnson DC, Hendricks RL Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response. J Exp Med. 187:1998;341-348. This paper describes that ICP47, although shown to have relatively low ability to block murine TAP in vitro, is a major neurovirulence factor in vivo.
13. Paabo S, Nilsson T, Peterson PA Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens. Proc Natl Acad Sci USA. 83:1986;9665-9669.
14. Sester M, Burgert HG Conserved cysteine residues within the E3/19K protein of adenovirus type 2 are essential for binding to major histocompatibility complex antigens. J Virol. 68:1994;5423-5432.
15. Jones TR, Wiertz EJHJ, Sun L, Fish KN, Nelson JA, Ploegh HL Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci USA. 93:1996;11327-11333.
16. Ziegler H, Thale R, Lucin P, Muranyi W, Flohr T, Hengel H, Farrell H, Rawlinson W, Koszinowski UH A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity. 6:1997;57-66.
17. Wiertz EJHJ, Tortorella D, Bogyo M, Yu J, Mothes W, Jones TR, Rapoport TA, Ploegh HL Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature. 384:1996;432-438.
18. Machold RP, Wiertz EJ, Jones TR, Ploegh HL The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J Exp Med. 185:1997;363-366. This paper describes the specificity of HCMV US2 and US11 for distinct murine MHC class I alleles, suggesting an explanation for the overlapping function and timing of US2 and US11 expression.
19. Schust DJ, Tortorella D, Seebach J, Phan C, Ploegh HL Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J Exp Med. 188:1998;497-503. This paper reports that HLA-C and HLA-G class I products are resistant to class I heavy chain degradation that is mediated by US2 and US11; moreover, the US2 and US11 molecules function in a porcine endothelial cell line - suggesting a potential role for these proteins in xenogeneic transplantation.
20. Kerkau T, Bacik I, Bennink JR, Yewdell JW, Hunig T, Schimpl A, Schubert U The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J Exp Med. 185:1997;1295-1305. The authors show that the HIV Vpu protein appears to decrease MHC class I protein levels in a manner analogous to HCMV US2 and US11.
21. Greenberg ME, Iafrate AJ, Skowronski J The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J. 17:1998;2777-2789. This paper describes the Nef-mediated accumulation of endocytosed MHC class I molecules in the trans-Golgi. This may be secondary to an interaction between Nef and the AP-1 complex.
22. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature. 391:1998;397-401. This paper reports that primary T lymphocytes infected with HIV clones containing Nef are protected from CTL-mediated lysis. Nef mediates a 300-fold reduction in surface expression of multiple MHC class I alleles.
23. Greenberg ME, Bronson S, Lock M, Neumann M, Pavlakis GN, Skowronski J Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J. 16:1997;6964-6976.
24. Waldman WJ, Knight DA, Adams PW Cytolytic activity against allogeneic human endothelia. Resistance of cytomegalovirus-infected cells and virally activated lysis of uninfected cells. Transplantation. 66:1998;67-77. This paper reports that allogeneic HCMV-infected endothelial cells are resistant to lysis by NK cells.
25. Browne H, Churcher M, Minson T Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted. J Virol. 66:1992;6784-6787.
26. Farrell HE, Vally H, Lynch DM, Fleming P, Shellam GR, Scalzo AA, Davis-Poynter NJ Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature. 386:1997;510-514.
27. Reyburn HT, Mandelboim O, Vales-Gomez M, Davis DM, Pazmany L, Strominger JL The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature. 386:1997;514-517.
28. Leong CC, Chapman TL, Bjorkman PJ, Formankova D, Mocarski ES, Phillips JH, Lanier LL Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med. 187:1998;1681-1687. This paper reports that UL18 enhances NK cell cytolysis of UL18-expressing cells; moreover, enhanced intercellular adhesion molecule (ICAM)-1 expression on HCMV-infected cells also appears to trigger NK cell cytolytic activity.
29. Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity. 7:1997;273-282. This paper describes the use of an Fc-UL18 construct to identify a receptor for UL18. The interaction between LIR-1 - expressed on monocytes, B cells and a minor subset of NK cells - and UL18 may mediate immunosuppressive effects in vivo.
30. Fletcher JM, Prentice HG, Grundy JE Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced downregulation of cell surface class I HLA. J Immunol. 161:1998;2365-2374. This paper shows that the susceptibility of HCMV-infected, class-I-negative cells to lysis by NK cells correlates with increased expression of LFA-3.
31. Cresswell P Invariant chain structure and MHC class II function. Cell. 84:1996;505-507.
32. Jonjic S, Mutter W, Weiland F, Reddehase MJ, Koszinowski UH Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4 T lymphocytes. J Exp Med. 169:1989;1199-1212.
33. Davignon JL, Castanie P, Yorke JA, Gautier N, Clement D, Davrinche C Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro. J Virol. 70:1996;2162-2169.
34. Lindsley MD, Torpey DJ III, Rinaldo CR Jr. HLA-DR restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells. J Immunol. 136:1986;3045-3051.
35. Fish KN, Britt W, Nelson JA A novel mechanism for persistance of human cytomegalovirus in macrophages. J Virol. 70:1996;1855-1862.
36. Tong X, Boll W, Kirchhausen T, Howley PM Interaction of the bovine papillomavirus E6 protein with the clathrin adaptor complex AP-1. J Virol. 72:1998;476-482. This paper describes and characterizes the interaction between BPV E6 protein and AP-1.
37. Boss JM Regulation of transcription of MHC class II genes. Curr Opin Immunol. 9:1997;107-113.
38. Sedmak DD, Guglielmo AM, Knight DA, Birmingham DJ, Huang EH, Waldman WJ Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am J Pathol. 144:1994;683-692.
39. Miller DM, Rahill BM, Boss JM, Lairmore MD, Durbin JE, Waldman WJ, Sedmak DD Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med. 187:1998;675-683. This paper reports that HCMV inhibits IFN-γ-stimulated MHC class II expression at the level of JAK/STAT signal transduction. There is an associated decrease in Jak1 protein.
40. Heise MT, Connick M, Virgin HW Murine cytomegalovirus inhibits interferon-γ-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes. J Exp Med. 187:1998;1-10. This paper reports that MCMV blocks IFN-γ-stimulated MHC class II expression without affecting JAK/STAT signal transduction.
41. Ayalon O, Hughes EA, Cresswell P, Lee J, O'Donnell L, Pardi R, Bender JR Induction of transporter associated with antigen processing by interferon γ confers endothelial cell cytoprotection against natural-killer-mediated lysis. Proc Natl Acad Sci USA. 95:1998;2435-2440.
42. Drezen JM, Babinet C, Morello D Transcriptional control of MHC class I and β2-microglobulin genes in vivo. J Immunol. 150:1993;2805-2813.
43. Silacci P, Mottet A, Steimle V, Reith W, Mach B Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J Exp Med. 180:1994;1329-1336.
44. Hobart M, Ramassar V, Goes N, Urmson J, Halloran PF IFN regulatory factor-1 plays a central role in the regulation of the expression of Class I and II MHC genes in vivo. J Immunol. 158:1997;4260-4269.
45. Ramassar V, Goes N, Hobart M, Halloran PF Evidence for the in vivo role of class II transactivator in basal and IFN-γ induced class II expression in mouse tissue. Transplantation. 62:1996;1901-1907.
46. Rinaldo CR Jr. Modulation of major histocompatibilty complex antigen expression by viral infection. Am J Pathol. 144:1994;637-650.
47. Leonard GT, Sen GC Restoration of interferon responses of adenovirus E1A-expressing HT1080 cell lines by overexpression of p48 protein. J Virol. 71:1997;5095-5101.
48. Leonard GT, Sen GC Effects of Adenovirus E1A protein on interferon-signaling. Virology. 224:1996;25-33.
49. Zeidler R, Eissner G, Meissner P, Uebel S, Tampe R, Lazis S, Hammerschmidt W Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10. Blood. 90:1997;2390-2397.